EpiPen RICO Ruling Opens Door for Private AKS Enforcement
Biosimilar Litigations include litigations relating to biosimilar/follow-on products of CDER-listed reference products. Litigations between biosimilar applicants/manufacturers and reference product sponsors as well as...more
As we ring in the new year, we look back at the top U.S. biosimilar market developments of 2020. Here are some of our highlights, in no particular order...more
Here are our picks for the top-five most significant U.S. market developments in the world of biosimilars in 2017...more